Relmada Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 1.23 M | $329.00 K | 0.00% | 4.04% |
| VANGUARD GROUP INC | 05/09/2025 | 1.21 M | $326.18 K | -3.87% | 3.97% |
| BLACKROCK, INC. | 05/02/2025 | 566.91 K | $153.06 K | -4.45% | 1.86% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 495.15 K | $133.69 K | 0.00% | 1.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 301.88 K | $81.53 K | -0.32% | 0.99% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 288.00 K | $77.76 K | 44.80% | 0.95% |
| ADVISORSHARES INVESTMENTS LLC | 05/13/2025 | 276.51 K | $75.65 K | 31.63% | 0.91% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 224.85 K | $60.71 K | 0.00% | 0.74% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 170.54 K | $46.05 K | 33.68% | 0.56% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 04/15/2025 | 163.34 K | $44.10 K | 0.00% | 0.54% |
| RBF CAPITAL, LLC | 05/15/2025 | 163.26 K | $44.08 K | 0.00% | 0.54% |
| UBS GROUP AG | 05/13/2025 | 144.79 K | $39.09 K | -32.70% | 0.48% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 124.10 K | $33.51 K | -24.57% | 0.41% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 120.85 K | $32.63 K | 100.00% | 0.40% |
| STATE STREET CORP | 05/15/2025 | 106.74 K | $28.82 K | 0.00% | 0.35% |
| MGO ONE SEVEN LLC | 05/08/2025 | 100.00 K | $27.00 K | 0.00% | 0.33% |
| NORTHERN TRUST CORP | 05/13/2025 | 59.57 K | $16.08 K | -29.32% | 0.20% |
| HRT FINANCIAL LP | 05/15/2025 | 52.04 K | $14.00 K | 100.00% | 0.17% |
| APRICUS WEALTH, LLC | 04/15/2025 | 48.96 K | $13.22 K | 0.00% | 0.16% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 42.80 K | $11.56 K | -96.71% | 0.14% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 40.27 K | $10.87 K | 0.00% | 0.13% |
| SEI INVESTMENTS CO | 05/14/2025 | 36.23 K | $9.78 K | 0.00% | 0.12% |
| CARTESIAN GROWTH CORP | 05/15/2025 | 31.98 K | $8.63 K | 0.00% | 0.11% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 28.64 K | $7.73 K | -71.94% | 0.09% |
| 05/13/2025 | 28.00 K | $7.56 K | 0.00% | 0.09% | |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 04/17/2025 | 25.00 K | $6.75 K | 0.00% | 0.08% |
| TORTOISE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 21.68 K | $5.85 K | 0.00% | 0.07% |
| PENSIONMARK FINANCIAL GROUP, LLC | 04/29/2025 | 21.64 K | $5.84 K | -27.09% | 0.07% |
| 05/12/2025 | 20.00 K | $5.40 K | 100.00% | 0.07% | |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 14.01 K | $3.78 K | 100.00% | 0.05% |
| LIDO ADVISORS, LLC | 05/15/2025 | 13.91 K | $3.75 K | 100.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 13.72 K | $3.70 K | -93.36% | 0.05% |
| STONEX GROUP INC. | 05/15/2025 | 13.23 K | $4.00 K | 100.00% | 0.04% |
| BEDEL FINANCIAL CONSULTING, INC. | 05/07/2025 | 10.00 K | $3.57 K | 0.00% | 0.03% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 4.48 K | $1.00 K | 100.00% | 0.01% |
| HEXAGON CAPITAL PARTNERS LLC | 04/29/2025 | 4.00 K | $1.08 K | 0.00% | 0.01% |
| AMERICAN CAPITAL ADVISORY, LLC | 04/28/2025 | 3.91 K | $1.06 K | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2025 | 2.17 K | $585 | -87.39% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 158 | $43 | -99.58% | 0.00% |
| 05/02/2025 | 102 | $28 | 0.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 72 | $19 | 0.00% | 0.00% |
| FRONT ROW ADVISORS LLC | 05/15/2025 | 6 | $2 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 5 | $1 | -84.38% | 0.00% |
| CITIGROUP INC | 05/12/2025 | 2 | $1 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| WOLVERINE TRADING, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Relmada Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of Relmada Therapeutics, Inc.. The most heavily invested institutionals were:
ACADIAN ASSET MANAGEMENT LLC: 1.23 M
VANGUARD GROUP INC: 1.21 M
BlackRock, Inc.: 566,905
Palo Alto Investors LP: 495,146
GEODE CAPITAL MANAGEMENT, LLC: 301,883
TWO SIGMA ADVISERS, LP: 288,000
20.45% of Relmada Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.96 M shares in the last 24 months. This purchase volume represents approximately $4.93 M in transactions.